Market Trends of Europe Medical Aesthetic Devices Industry
Breast Implant Segment is Expected to Witness Significant Growth over the Forecast Period
- The aesthetics devices market is expected to witness significant growth in the breast implant segment over the forecast period. This growth can be attributed to several factors, including the increasing prevalence of breast cancer among the population, growing awareness about physical appearance and beauty, and the availability of a variety of breast implants.
- The rising number of breast augmentation procedures in the region is also contributing to the growth of the segment. This is driving the demand for technologically advanced aesthetic devices and breast implants. For instance, according to the International Society of Aesthetic Plastic Surgery's 2021 statistics, Germany and Spain alone performed 66,945 and 37,944 breast augmentation procedures, respectively.
- Moreover, the increasing number of product launches is making more advanced breast implants available in the region, further contributing to market growth. For example, in May 2022, GC Aesthetics, Inc. launched FixNip NRI, its Nipple Areola Complex Reconstruction Implants, to cater to women's clinical needs.
- In May 2021, GC Aesthetics launched PERLE, the next generation of breast implants, a highly innovative line of smooth breast implants with surface technology (BioQ), in Europe. This launch helped the company to offer the broadest product portfolio with a full selection of surfaces, fillings, sizes, and projections to meet every patient's and surgeon's demands for both reconstructive and aesthetic procedures.
- Therefore, the high burden of breast cancer, along with the rising number of product launches, is expected to drive the growth of the studied market over the forecast period.
Germany is Expected to Have the Significant Market Share Over the Forecast Period
Germany is anticipated to hold a significant share of the medical aesthetics market over the forecast period owing to the factors such as the high burden of breast cancer, increasing aesthetic procedures, the growing geriatric population as well as rising product launches.
As per the statistics published by the International Society of Aesthetic Plastic Surgery, about 476,951 surgical procedures and 605,942 non-surgical procedures were performed in Germany in 2021. In addition, about 66,945 breast augmentation surgical procedures and 306,296 botulinum toxin non-surgical procedures were performed in Germany in 2021. As per the same source, Germany reported 806 chemical peel procedures in 2021. Thus, the increasing number of aesthetic procedures requires medical aesthetic devices, hence propelling the market growth in Germany over the forecast period.
The rising burden of breast cancer among the population increases the need for breast surgeries which in turn is anticipated to fuel the demand for different types of breast implants, thereby propelling the market growth. For instance, as per 2023 statistics published by the Global Cancer Observatory, about 70,721 breast cancer cases are expected to be diagnosed in Germany in 2025 as compared to 69,697 cases during the pandemic. In addition, this number is projected to reach 71,799 by 2030.
Furthermore, the rising product launches in the country are also contributing to the market growth over the forecast period. For instance, in April 2022, Sinclair Pharma announced the company has received the European CE mark for Perfectha Lidocaine in the treatment of wrinkle correction, facial contouring, and volume restoration. This CE certificate results in the launch of Perfectha Lidocaine in the United Kingdom and all major European markets.
Therefore, due to the aforementioned factors, such as increasing breast cancer cases, growing demand for aesthetic procedures, and rising product launches, the studied market is expected to grow over the forecast period.
